Outlook Therapeutics (NASDAQ:OTLK) Receives New Coverage from Analysts at Oppenheimer

Retrieved on: 2019-06-09 11:45:00

Tags for this article:

Click the tags to see associated articles and topics

Outlook Therapeutics (NASDAQ:OTLK) Receives New Coverage from Analysts at Oppenheimer. View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC bought a new stake in Outlook Therapeutics, Inc. (NASDAQ:OTLK) during the first quarter, according to the company ...</div>

Article found on:

View Original Article